Table 1 Pathologic characteristics of tumors used in this study.
From: Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion
Analysis | Patient ID | Age at RP (years) | PSA at RP (ng/mL) | Gleason Grade | Pathologic Stage |
|---|---|---|---|---|---|
transcriptomics | 1921 | 52 | 6.3 | 4 + 3 = 7 | PT3A |
transcriptomics | 1963 | 59 | 12 | 5 + 5 = 10 | PT3A |
transcriptomics | 1967 | 70 | 13 | 4 + 3 = 7 | PT3B |
transcriptomics | 1970 | 56 | 2.4 | 3 + 4 = 7 | PT2C |
transcriptomics | 2100 | 63 | 19.6 | 4 + 3 = 7 | PT3B |
transcriptomics | 2117 | 51 | 8 | 3 + 4 = 7 | PT3A |
proteomics | 1381 | 60 | 7.7 | 4 + 3 = 7 | PT3B |
proteomics | 1411 | 58 | 5.7 | 3 + 4 = 7 | PT2C |
proteomics | 1420 | 62 | 5.1 | 3 + 4 = 7 | PT3A |
proteomics | 1424 | 66 | 9.1 | 3 + 3 = 6 | PT3A |
proteomics | 1439 | 63 | 6.8 | 3 + 3 = 6 | PT2C |
proteomics | 1455 | 61 | 5.2 | 5 + 4 = 9 | PT3B |
proteomics | 1463 | 67 | 15 | 4 + 3 = 7 | PT2C |
proteomics | 1490 | 66 | 6.4 | 4 + 3 = 7 | PT3B |
proteomics | 1581 | 63 | 17 | 4 + 3 = 7 | PT3A |
proteomics | 1596 | 66 | 6.6 | 4 + 5 = 9 | PT3A |
proteomics | 1622 | 72 | 13 | 3 + 4 = 7 | PT2C |
proteomics | 1628 | 74 | 7.1 | 3 + 4 = 7 | PT2C |
